THERAPEUTICSMD INC - COM (TXMD)

CUSIP: 88338N107

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class
Equity / COM
Total 13F shares
164,362,294
Share change
+9,147,306
Total reported value
$948,393,873
Put/Call ratio
109%
Price per share
$5.77
Number of holders
144
Value change
+$51,055,130
Number of buys
83
Number of sells
57

Quarterly Holders Quick Answers

What is CUSIP 88338N107?
CUSIP 88338N107 identifies TXMD - THERAPEUTICSMD INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERAPEUTICSMD INC - COM (TXMD) as of Q4 2016

As of 31 Dec 2016, THERAPEUTICSMD INC - COM (TXMD) was held by 144 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 164,362,294 shares. The largest 10 holders included FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, Bank of New York Mellon Corp, JPMORGAN CHASE & CO, FRANKLIN RESOURCES INC, VANGUARD GROUP INC, BlackRock Fund Advisors, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Institutional Trust Company, N.A., and STATE STREET CORP. This page lists 144 institutional shareholders reporting positions in this security for the Q4 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.